Polpharma API

Polish CDMO for active pharmaceutical ingredients. Part of Polpharma Group, one of the largest pharma companies in Poland. Multi-purpose plant meeting EU GMP and FDA standards. Offers custom API development and manufacturing with peptide-related capabilities.

Polpharma API is listed as a CDMO in the peptide supply chain, serving Europe markets from Poland. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 1 independent source, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.